Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer ...
Eric has held commercial leadership roles in large and small pharmaceutical companies in the US, Canada, and Switzerland. Over his 20-year tenure at Merck & Co., Inc., Eric helped to integrate ...
Bernstein has recently initiated Merck & Co Inc (MRK) stock to Mkt Perform rating, as announced on October 17, 2024, according to Finviz. Earlier, on March 11, 2024, Societe Generale had reduced the ...